Zurich Cantonal Bank’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,031
| Closed | -$104K | – | 2609 |
|
|
2025
Q1 | $104K | Buy |
47,031
+16,914
| +56% | +$37.4K | ﹤0.01% | 2374 |
|
|
2024
Q4 | $164K | Buy |
30,117
+4,667
| +18% | +$25.4K | ﹤0.01% | 2239 |
|
|
2024
Q3 | $211K | Hold |
25,450
| – | – | ﹤0.01% | 2078 |
|
|
2024
Q2 | $182K | Buy |
25,450
+6,212
| +32% | +$44.5K | ﹤0.01% | 2086 |
|
|
2024
Q1 | $167K | Hold |
19,238
| – | – | ﹤0.01% | 2151 |
|
|
2023
Q4 | $126K | Sell |
19,238
-4,936
| -20% | -$32.3K | ﹤0.01% | 2337 |
|
|
2023
Q3 | $242K | Buy |
24,174
+7,264
| +43% | +$72.6K | ﹤0.01% | 1853 |
|
|
2023
Q2 | $210K | Hold |
16,910
| – | – | ﹤0.01% | 1895 |
|
|
2023
Q1 | $237K | Sell |
16,910
-684
| -4% | -$9.58K | ﹤0.01% | 1768 |
|
|
2022
Q4 | $252K | Buy |
17,594
+2,988
| +20% | +$42.8K | ﹤0.01% | 1690 |
|
|
2022
Q3 | $373K | Hold |
14,606
| – | – | ﹤0.01% | 1367 |
|
|
2022
Q2 | $415K | Sell |
14,606
-1,923
| -12% | -$54.6K | ﹤0.01% | 1342 |
|
|
2022
Q1 | $583K | Buy |
16,529
+2,177
| +15% | +$76.8K | ﹤0.01% | 1255 |
|
|
2021
Q4 | $601K | Buy |
14,352
+5,040
| +54% | +$211K | ﹤0.01% | 1309 |
|
|
2021
Q3 | $457K | Hold |
9,312
| – | – | ﹤0.01% | 1357 |
|
|
2021
Q2 | $389K | Buy |
+9,312
| New | +$389K | ﹤0.01% | 1376 |
|